Digital Health Startup Funding 2025-2026

What are all the funding deals in the digital health market from May 2025 to April 2026?

The table below lists every disclosed equity round raised by pure-play digital health companies between May 2025 and April 2026. We count as "pure-play" digital health companies those focused on telehealth and virtual care, remote monitoring and connected devices, health IT and clinical workflow software, or patient-facing mobile apps with a clear health use case.

Each row shows the company, what it does, its category, the deal date, the funding stage, the round size, the region, the main investors, and the announcement source. For a wider view of how digital health fits inside the broader healthcare technology opportunity, we cover it in our Digital Health market deck.

How active has fundraising been in the digital health market?

As of April 2026, fundraising in the digital health market has been consistently active. Over the past 12 months, companies raised 30 disclosed equity rounds and $1.38B combined, which works out to 2.5 deals per month and $115.4M of capital per month on average.

Company formation in the digital health market is broad. The 30 disclosed deals came from 30 unique companies, which means no single company raised twice during the window and new entrants kept surfacing month after month.

Monthly capital swings are noticeable, and the mean and median diverge. Average monthly capital is $115.4M while median monthly capital is $86.5M, which confirms that a few larger months pulled the average up rather than the market rising evenly.

February 2026 was the standout month in the digital health market, with $483M raised across 4 deals thanks to Talkiatry, Honest Health, Garner Health, and Rainfall Health. July 2025 had no qualifying disclosed deal at all.

If you're interested in knowing more about the top startups in this industry, check our market report covering digital health.

How concentrated has fundraising been in the digital health market?

As of April 2026, fundraising in the digital health market is moderately concentrated at the top. Over the past 12 months, the single largest deal accounts for 15.2% of all capital raised, the top 3 deals reach 35.0%, and the top 5 reach 48.2%.

The Talkiatry Series D+ round alone accounts for 15.2% of all disclosed capital in the digital health market. That single $210M round is more than twice the size of every European deal combined and larger than the entire Health Data Infrastructure category.

The top 10 deals captured 66.5% of all disclosed capital, which means roughly one-third of companies drove two-thirds of the dollars. The rest of the 30-deal dataset still matters, but the dollar-weighted story is shaped by a minority of rounds.

This concentration means total-market headlines can be misleading. Before assuming the whole digital health market is moving, it is worth asking which three or four deals actually drove the total capital number.

How much of the digital health funding signal is driven by outliers?

As of April 2026, a meaningful share of the funding signal in the digital health market comes from outliers, but less than in younger hardware-heavy markets. Over the past 12 months, 7 of 30 disclosed deals cleared $50M and 4 cleared $100M, so megarounds set the dollar totals while mid-market rounds set the deal count.

Rounds above $50M make up only 23.3% of disclosed deals in the digital health market, yet they capture roughly 56% of disclosed capital. That disproportion is why the same dataset can look "broad" on deal count and "concentrated" on dollars at the same time.

Rounds above $100M represent just 13.3% of disclosed deals, or 4 rounds total. This is a much lower megaround density than what is seen in markets driven by hardware scale-up bets.

A simple stress test is to strip the $50M+ rounds. Removing them takes out around 56% of disclosed capital and leaves $614.4M across 23 rounds, which confirms that the digital health market still has a healthy mid-market spine underneath the big headlines.

If you want to go deeper on this, we cover it in our deeper analysis of the digital health market.

Is the digital health market broad with many targets, or narrow with few fundable companies?

As of April 2026, the digital health market is broad rather than narrow. All 30 disclosed rounds over the past 12 months came from 30 unique companies, so there were no repeat raisers inside this window.

Stage distribution reinforces the breadth. Series A holds 14 of 30 deals, Series B holds 5, Growth Equity holds 4, Series D+ holds 3, Unknown holds 3, and Series C holds 1. That spread shows investors are funding companies at multiple points of maturity, not just one.

Deal size distribution points the same way. The $20M to $50M band alone holds 12 deals, the $5M to $20M band holds 9 deals, and the $50M+ band holds 9 deals, which creates an unusually balanced spine for a healthcare-tech vertical.

The one real tightness in the digital health market is at the bottom of the stack. There were no disclosed rounds below $5M during this 12-month window, which suggests seed-stage activity either shifted above the $5M line or increasingly went unannounced.

Is digital health mostly an early-stage formation market or a late-stage scaling market?

As of April 2026, the digital health market tilts slightly toward late-stage scaling rather than early-stage formation. Late-stage and growth capital held 51.9% of disclosed dollars over the past 12 months, while Series A and Series B combined held 43.2%.

Early-stage activity in the digital health market is strong on deal count. Series A alone captures 46.7% of all disclosed deals, which makes it the modal stage of the window, even though it only holds 22.3% of capital.

Late-stage rounds are less frequent but carry the biggest checks. Series D+ represents only 10% of disclosed deals but 27.3% of disclosed capital, with an average round size of $126M versus $22.1M at Series A. That gap is what pulls the capital distribution toward the later stages.

Follow-on rounds dominate the digital health market. 28 of 30 disclosed deals are follow-ons, which means investors keep concentrating capital on companies that already closed at least one prior round rather than seeding many new category entrants.

If you want to learn more about what investors are currently betting on, check out our report on the digital health market.

Which categories attract the most investor attention in digital health?

As of April 2026, Clinical Workflow Software attracts the most investor attention in digital health by a wide margin. Over the past 12 months, the category accounts for 12 of 30 disclosed deals and $467.8M raised, which is 40.0% of all deals and 33.8% of all disclosed capital.

Clinical Workflow Software benefits from a clear buyer with budget authority. Companies like Honest Health, Medallion, Adonis, and Thesis Care keep raising because health systems and provider groups pay to reduce administrative load, credentialing friction, and reimbursement leakage.

Virtual Care Platforms and Care Navigation Platforms come next on capital even though they trail on deal count. Each category captured 13.3% of disclosed deals but contributed 21.6% and 19.5% of disclosed capital, respectively, driven by larger rounds at Talkiatry, Sprinter Health, Angle Health, and Garner Health.

Patient Engagement Tools, Remote Monitoring Solutions, and Health Data Infrastructure sit further down. Together they hold 33.3% of disclosed deals but only 25.1% of disclosed capital, which shows they are funded but not yet priced at premium sizes in the digital health market.

Which categories attract disproportionately large checks in the digital health market?

As of April 2026, Virtual Care Platforms attract the most disproportionately large checks in the digital health market. Over the past 12 months, the category closed only 4 deals but raised $299.5M, which gives it a capital-to-deal share ratio of 1.62x.

Care Navigation Platforms sit close behind with a capital-to-deal ratio of 1.46x. Companies that can influence benefit design or provider selection, like Angle Health and Garner Health, absorb much larger checks than information-only navigation tools.

Clinical Workflow Software is crowded rather than outsized on check ratio. The category has 40% of deals but a capital-to-deal ratio of only 0.84x, which means investors fund many workflow point solutions but concentrate only some of their dollars there.

Health Data Infrastructure and Remote Monitoring Solutions lag on check size. Their capital-to-deal ratios sit at 0.57x and 0.71x, which confirms that infrastructure layers and device-driven monitoring in the digital health market are still funded more modestly than care-delivery and benefits-linked plays.

For more context on how these categories stack up, see our full market deck on digital health.

Which geographies matter most for fundraising in the digital health market?

As of April 2026, North America is the only geography that truly matters for digital health fundraising. Over the past 12 months, North America captured $1,292.4M from 28 disclosed deals, which is 93.4% of disclosed capital and 93.3% of disclosed deals.

North America leads the digital health market on both dollars and deal count. The region produced an average round size of $46.2M and a median of $28.8M, and it is where every single $100M+ round in the dataset was closed.

Europe is the only other region with disclosed activity in the digital health market. Europe contributed 2 deals totaling $92M, with an average round size of $46M, which is almost identical to North America's average.

The interesting nuance in the digital health market is that Europe's problem is deal frequency, not deal size. When European digital health companies do raise, they raise at North American scale, but those rounds happen far less often.

If you want to identify the opportunities currently emerging in this market, explore our market pitch on digital health.

Is the digital health opportunity set broad or concentrated in one hub?

As of April 2026, the digital health opportunity set is concentrated in one hub, not spread across several. North America alone holds 93.4% of disclosed capital and 93.3% of disclosed deals over the past 12 months, leaving very little for the rest of the world.

Europe represents only 6.6% of disclosed capital in the digital health market, spread across 2 deals. Aktiia (now Hilo) at $42M and voize at $50M are the only European digital health rounds in the entire 12-month window.

Asia-Pacific, Latin America, the Middle East, and Africa contributed no disclosed deals in the digital health market. Investors may still be active in those regions, but they did not produce category-fitting, pure-play, $300K+ public rounds in this sample.

This regional concentration matters for interpretation. Commentary about a "global digital health recovery" based on the disclosed equity market is really commentary about North America, with a small and occasional contribution from Europe.

Is digital health a market of small experiments or scaled financings?

As of April 2026, the digital health market runs on mid-sized financings rather than small experiments or heavy megarounds. 21 of 30 disclosed rounds sit between $5M and $50M over the past 12 months, and the median round size is $32.3M.

The size distribution is unusually balanced for a healthcare-tech vertical. 0 deals sit under $5M, 9 deals sit between $5M and $20M, 12 deals sit between $20M and $50M, and 9 deals sit at $50M or more. That means 70% of digital health rounds land in the mid-market band.

Megarounds exist but are not the dominant mode of the digital health market. Only 7 of 30 disclosed deals clear $50M strictly, and 4 clear $100M, so the vast majority of companies are funded at sub-megaround sizes.

The average round size in the digital health market is $46.1M, but that number is lifted by the Talkiatry, Honest Health, Angle Health, and Garner rounds. The median of $32.3M is a much more reliable indicator of what investors actually write per deal.

If you want to stay on top of the latest trends, risks, and opportunities in this market, check out our market report on digital health, updated every quarter.

Who are the investors that appear the most in digital health fundraising?

As of April 2026, only ten investors appear in more than one disclosed digital health round. Most of those repeat appearances are spread across different companies rather than doubling down on a single portfolio name.

General Catalyst is the most active repeat investor in the digital health market, showing up in 4 disclosed deals. That repeat presence suggests a portfolio-level thesis around healthcare operations and infrastructure, not a set of isolated bets.

Nine investors tie for second place with 2 disclosed deals each. Andreessen Horowitz, Bling Capital, CRV, Jackson Square Ventures, Kaiser Permanente Ventures, Khosla Ventures, Maverick, Oak HC/FT, and Y Combinator all appear twice in the dataset.

The mix of repeat names is informative. Several of them are crossover investors comfortable underwriting both health-system complexity and AI/software speed, which is consistent with where the biggest checks actually landed during this 12-month window.

One important caveat: round announcements in the digital health market rarely disclose how much each investor actually contributed. Any "dollars by investor" figure should be read as the total round size an investor participated in, not the amount they personally committed.

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living "market pitch" documents for emerging markets: AI, synthetic biology, new proteins, and more. Instead of outdated PDFs or hallucinated LLM answers, our clients get a clean, visual, always-updated view of what's really happening: key players, deals, regulations, and signals that matter. Learn more about us.